Agenda At-A-Glance

Tuesday, September 5

  • 15:00 to 17:00
    Registration
  • 17:00 to 18:00
    Keynote: Modifying Genomic DNA and RNA
  • 18:00 to 19:30
    Opening Reception

Wednesday, September 6

  • 8:30 to 10:30
    Therapeutic Targeting of RNA
  • 10:30 to 11:00
    Coffee Break - Green Room
  • 11:00 to 11:30
    Epigenetic Mechanisms in Congenital Myotonic Dystrophy
  • 11:30 to 12:30
    DM Session 1: Microsatellite Instability and Epigenetics
  • 12:30 to 13:00
    Flash Poster Session
  • 13:00 to 14:30
    Lunch
  • 13:00 to 14:30
    Poster Viewing
  • 14:30 to 17:00
    DM Session 2: Disease Mechanisms DM1, DM2 and CDM

Thursday, September 7

  • 8:30 to 9:00
    Pathogenic Mechanisms of C9orf72 Repeat Expansion
  • 9:30 to 10:00
    DM Session 3: Cancer and Aging in DM
  • 10:00 to 10:30
    Coffee Break - Green Room
  • 10:30 to 12:00
    DM Session 4: Clinical, Ethical and Social Issues, and Disease Burden
  • 12:00 to 12:30
    Flash Poster Session
  • 12:30 to 14:00
    Poster Viewing
  • 12:30 to 14:00
    Lunch
  • 14:00 to 16:30
    DM Session 5: Specific Disease Features: CNS, Cardiac and GI
  • 16:30 to 17:00
    Organization and Outreach Update

Friday, September 8

  • 8:30 to 9:30
    CNS and Sleep
  • 9:30 to 10:30
    DM Session 6: Cell Models for DM
  • 10:30 to 11:00
    Coffee Break - Green Room
  • 11:00 to 12:00
    DM Session 7: Animal Models and Tissue-specific Mechanisms
  • 12:00 to 12:30
    Flash Poster Session
  • 12:30 to 13:30
    Lunch
  • 12:30 to 13:30
    Poster Viewing
  • 13:30 to 16:30
    Neuromuscular Clinical Research Experience
  • 16:30 to 17:30
    DM Session 8: RNA Clinical Research Methods: Biomarkers, Outcome Measures, Registries, Trial Design and Therapeutics
  • 19:30 to 21:30
    Closing Dinner

Saturday, September 9

  • 7:00 to 9:00
    Drug Development Roundtable
  • 8:00 to 9:00
    Breakfast and MDF Research Update
  • 9:00 to 9:45
    IDMC Awards
  • 9:45 to 10:00
    Coffee Break
  • 10:00 to 12:00
    Bringing the Patient Voice to CNS-Targeting Drug Development in Myotonic Dystrophy
  • 12:00 to 13:00
    Bringing the Patient Voice to CNS - Facilitated Lunch Discussion and Report Out
  • 13:00 to 13:45
    Grant Writing Training
  • 15:30 to 17:00
    Expanding the Pipeline: Industry Updates on Drug Development